Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1 Clinical correlates of neurodegeneration in MS

Published byXavier Pérez Piñeiro Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 1 Clinical correlates of neurodegeneration in MS"— Presentation transcript:

1 Figure 1 Clinical correlates of neurodegeneration in MS
Part a adapted by permission from BMJ Publishing Group Limited. J. Neurol. Neurosurg. Psychiatry, Scalfari, A. et al., 85, 67–75, © Part b: Scalfari, A. et al., The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability, Brain 133 (Pt 7) (2010), 1914–1929 by permission of Oxford University Press Friese, M. A. et al. (2014) Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis Nat. Rev. Neurol. doi: /nrneurol

Download ppt "Figure 1 Clinical correlates of neurodegeneration in MS"

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.
Nat. Rev. Neurol. doi:10/1038/nrneurol

Nat. Rev. Neurol. doi:10/1038/nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Electromechanical properties of OIHPs

Figure 2 Electromechanical properties of OIHPs
Figure 6 Selected examples of TERS applications in material systems

Figure 6 Selected examples of TERS applications in material systems
Figure 3 Life expectancy at birth in all countries included

Figure 3 Life expectancy at birth in all countries included
Figure 1 Perivenous distribution of multiple sclerosis lesions

Figure 1 Perivenous distribution of multiple sclerosis lesions
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 The US Centers for Disease Control and

Figure 2 The US Centers for Disease Control and
Figure 4 Time course of the development of physiological changes

Figure 4 Time course of the development of physiological changes
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 8 Implanted devices for the management of heart failure

Figure 8 Implanted devices for the management of heart failure
Figure 2 Bad-metal behaviour and electron correlations

Figure 2 Bad-metal behaviour and electron correlations
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Proportion of patients for whom NEDA

Figure 3 Proportion of patients for whom NEDA
Figure 5 Number of AHSCT procedures for

Figure 5 Number of AHSCT procedures for
Figure 4 Neuromyelitis optica spectrum disorder brain lesions

Figure 4 Neuromyelitis optica spectrum disorder brain lesions
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Similar presentations

Ads by Google